About Daniel

Daniel I. Goldberg represents public and private companies and financial institutions in connection with securities offerings, mergers and acquisitions and general corporate matters. He has particular experience handling initial public offerings, follow-on offerings, shelf-takedowns, registered directs, PIPEs and Regulation S offerings. Daniel is a market leader in advising issuers and underwriters in "at-the-market" (ATM) offerings, which are an efficient way to raise working capital, fund specific projects, fund research and development or pay off debt.

View full bio

Experience

Forward Industries Announces $1.65 Billion PIPE Offering

Forward Industries Announces $1.65 Billion PIPE Offering

September 11, 2025

Cooley advised Jump Crypto as a sponsor in connection with $1.65 billion in cash and stablecoin commitments for a private investment in public equity (PIPE) offering by Forward Industries, a global design company serving top-tier medical and technology companies, to initiate a Solana-focused digital asset treasury strategy, aligning Forward Industries with the fast-growing Solana ecosystem.

Read more

Related contacts

Yvan-Claude Pierre
Partner, New York
Daniel I. Goldberg
Partner, New York
Derek Colla
Partner, Miami
Stephanie Gentile
Partner, New York
Minkyu Park
Special Counsel, New York
David Peinsipp
Partner, San Francisco
Samuel Paullin
Associate, Chicago
Leah Duncan
Associate, Chicago
Benjamin Shulman
Associate, New York
Todd Gluth
Partner, San Diego

Related Practices & Industries

Capital Markets
Blockchain Technology and Tokenization
Venture Capital
Tax
Emerging Companies

GameStop Announces $2.25 Billion Convertible Senior Notes Offering

GameStop Announces $2.25 Billion Convertible Senior Notes Offering

June 12, 2025

Cooley advised the initial purchaser of GameStop in connection with GameStop’s offering of $2.25 billion aggregate principal amount of 0.00% convertible senior notes due 2032.

Read more

Related contacts

Jason Savich
Partner, San Francisco
Mischi a Marca
Partner, San Francisco
Daniel I. Goldberg
Partner, New York
Grady Chang
Associate, Santa Monica
Annie Froehlich
Partner, Washington, DC
Claire Keast-Butler
Co-Partner in Charge – London, London
Kevin King
Partner, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Rodrigo Seira
Special Counsel, Miami
Eric J. Delgado
Associate, New York
Matthew Iannone
Associate, New York
Allison Kutner
Associate, New York
Calvin Lee
Associate, New York
Xueqing Li
Associate, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles
Melanie Simon-Giblin
Associate, New York
Philip Whitehead
Associate, London

Related Practices & Industries

Debt Finance
Capital Markets
Gaming and Interactive Media
Technology
Tax
Cyber/Data/Privacy
CFIUS

Aclaris Therapeutics Announces Global License Agreement With Biosion, $80 Million Private Placement

Aclaris Therapeutics Announces Global License Agreement With Biosion, $80 Million Private Placement

November 18, 2024

Cooley advised Aclaris Therapeutics (Nasdaq: ACRS), a clinical-stage biopharmaceutical company developing novel drug candidates for immuno-inflammatory diseases, on its exclusive license agreement with Biosion and $80 million private placement.

Read more

Related contacts

Mark Ballantyne
Partner, Reston
Kenneth Krisko
Partner, Reston
J. Brian Stalter
Special Counsel, New York
Ruomu Li
Partner, Shanghai
David Brinton
Associate, Washington, DC
Arjan Ganji
Associate, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Daniel I. Goldberg
Partner, New York
Christopher Kimball
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Francis Wheeler
Senior Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
John Forrest
Associate, Boston
Zack Gong
Associate, Shanghai
Michael Shen
Special Counsel, Shanghai
Robin K. Lee
Paralegal Specialist, Colorado

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences
Mergers and Acquisitions
Capital Markets
Life Sciences and Healthcare Regulatory
CooleyREG
Tax

Gamida Cell Completes International Restructuring

Gamida Cell Completes International Restructuring

June 21, 2024

Cooley advised long-time biotech client, Gamida Cell Ltd., and its wholly-owned subsidiary, Gamida Cell Inc. (collectively, the “Company”), in the Company’s global restructuring through a novel use of debt arrangement proceedings in Israel combined with Chapter 15 and 11 proceedings in the United States. 

Read more

Related contacts

Michael Klein
Partner, New York
Olya Antle
Associate, Washington, DC
Ben Thomson
Associate, Chicago
Erin J. Kirchner
Partner, Chicago
Div Gupta
Partner, New York
Daniel I. Goldberg
Partner, New York
Mateus Kaba Aboud
Associate, Chicago
Jeremiah P. Ledwidge
Associate, New York
Yoni Horn
Associate, Santa Monica
Mischi a Marca
Partner, San Francisco

Related Practices & Industries

Business Restructuring
Debt Finance
Life Sciences

Cidara Therapeutics Announces Concurrent Reacquisition of IP Rights to CD388, $240 Million PIPE Financing

Cidara Therapeutics Announces Concurrent Reacquisition of IP Rights to CD388, $240 Million PIPE Financing

May 1, 2024

Cooley advised Cidara Therapeutics (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, on its concurrent $240 million private placement financing and definitive agreement with Janssen Pharmaceuticals, a Johnson & Johnson Company, to reacquire the exclusive global development and commercial rights to CD388.

Read more

Related contacts

Charles Bair
Partner, San Diego
Jane Adams
Partner, San Diego
Barbara Borden
Senior Counsel, San Diego
Megan Browdie
Partner, Washington, DC
Daniel I. Goldberg
Partner, New York
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Francis Wheeler
Senior Counsel, Colorado
Sharon Connaughton
Special Counsel, Washington, DC
Asa Henin
Partner, San Diego
Gaël Y. Hagan
Special Counsel , Colorado
Michelle Hunt
Associate
Edmond Lay
Partner, San Diego
Kyrsten Lundh
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles
Kelly Nelle
Paralegal Specialist, San Diego

Related Practices & Industries

Biotechnology
Life Sciences
Life Sciences Corporate Partnering and Licensing
Intellectual Property
Mergers and Acquisitions
Capital Markets
Antitrust and Competition
Tax
View more

Admissions and credentials

New Jersey

New York

Rankings and accolades

Legal 500 US: Capital Markets: Equity Offerings (2013-2014)

Memberships and affiliations

Certified Public Accountant - Maryland

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.